Hermans, Maud A W <br/><br/>
The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.  [electronic resource] 

 -  Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology  11 2018 
 - 1412-1420 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2222 
<br/><br/><label>Standard No.: </label>10.1111/cea.13217  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers<br/>Cell Degranulation--drug effects<br/>Cell Line<br/>Cytokines--biosynthesis<br/>Humans<br/>Janus Kinase 1--antagonists & inhibitors<br/>Janus Kinase 2--antagonists & inhibitors<br/>Mast Cells--drug effects<br/>Nitriles<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrimidines<br/>Signal Transduction--drug effects